Rigel Pharmaceuticals, Inc. (RIGL)

Last Closing Price: 29.01 (2026-05-22)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Rigel Pharmaceuticals, Inc. (RIGL) had Net Income of $8.65M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$58.82M
Net Income
$8.65M
$4.61M
$54.21M
$46.93M
$11.88M
$-0.23M
$11.66M
$11.66M
$8.65M
$8.65M
$8.65M
$8.65M
$11.88M
$12.31M
18.41M
19.69M
$0.47
$0.44
Balance Sheet Financials
$234.03M
--
$270.58M
$504.61M
$89.49M
$14.99M
$15.22M
$104.71M
$399.90M
$375.74M
$399.90M
18.48M
Cash Flow Statement Financials
$2.73M
$-7.97M
$-10.92M
$40.64M
$24.47M
$-16.17M
$3.46M
--
--
Fundamental Metrics & Ratios
2.62
--
--
0.04
0.11
92.17%
20.21%
20.21%
--
19.82%
14.71%
$2.73M
--
--
--
0.12
0.40
1.18
76.42
2.16%
2.30%
1.72%
2.09%
$21.64
$0.14
$0.14